- Did you mean
- disease
Search results - 2 results
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.
therapy were lung transplantation, cystic fibrosis-related diabetes (CFRD), moderate or severe lung disease and azithromycin use (often considered a surrogate marker for infection and poorer lung function). ...
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.
Publication Type: Peer reviewed scientific article Authors: Siobhán B Carr; Elliot McClenaghan; Alexander Elbert; Albert Faro; Rebecca Cosgriff; Olzhas Abdrakhmanov; Keith Brownlee; Pierre-Régis Burgel; Catherine A Byrnes; Stephanie Y Cheng; Colombo, Carl ...